Quick Answer
OCTAVE SPECIALTY GROUP INC reported Total Revenue of $251.22 million for fiscal year 2025.
OCTAVE SPECIALTY GROUP INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $251.22M +6.5% |
$235.81M +89.1% |
$124.73M +132.6% |
$53.61M -81.0% |
$282.00M +80.8% |
$156.00M -68.5% |
| Net Income | -$259.09M +53.4% |
-$556.09M -11331.8% |
$4.95M -99.1% |
$522.12M +3171.3% |
-$17.00M +96.1% |
-$437.00M -102.3% |
| Diluted EPS | -$5.93 +50.4% |
-$11.96 -6744.4% |
$0.18 -98.4% |
$11.48 +1982.0% |
-$0.61 +93.6% |
-$9.47 -101.9% |
| Total Assets | $2.22B -72.4% |
$8.06B -4.4% |
$8.43B +5.7% |
$7.97B -35.2% |
$12.30B -6.9% |
$13.22B -0.8% |
| Cash and Equivalents | — | — | — | — | $17.00M -15.0% |
$20.00M -16.7% |
| Long-Term Debt | $100.00M | $0.00 -100.0% |
$508.00M -20.5% |
$639.00M -71.3% |
$2.23B -18.6% |
$2.74B -2.9% |
| Stockholders Equity | $715.79M -10.3% |
$798.36M -41.4% |
$1.36B +8.8% |
$1.25B +20.6% |
$1.04B -3.9% |
$1.08B -26.9% |
| Shares Outstanding | 45.01M -3.2% |
46.51M +2.9% |
45.20M +0.5% |
44.97M -2.9% |
46.30M +1.1% |
45.81M +0.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $66.61M | -4.9% | +21.2% |
| Net Income | September 30, 2025 | -$112.62M | -309.5% | -54.9% |
| Diluted EPS | September 30, 2025 | -$2.35 | -273.0% | -52.6% |
| Total Assets | September 30, 2025 | $2.15B | -76.8% | -74.8% |
| Cash and Equivalents | September 30, 2022 | $29.00M | +107.1% | -9.4% |
| Long-Term Debt | September 30, 2024 | $518.00M | +2.6% | +0.6% |
| Stockholders Equity | September 30, 2025 | $843.38M | -42.4% | -1.9% |
| Shares Outstanding | September 30, 2025 | 46.70M | -1.6% | +0.6% |
- OCTAVE SPECIALTY GROUP INC reported Total Revenue of $251.22 million for fiscal year 2025.
- OCTAVE SPECIALTY GROUP INC showed an increase of +6.5% in Total Revenue compared to the prior fiscal year.
- OCTAVE SPECIALTY GROUP INC reported Net Income of -$259.09 million for fiscal year 2025.
- OCTAVE SPECIALTY GROUP INC showed an increase of +53.4% in Net Income compared to the prior fiscal year.
- OCTAVE SPECIALTY GROUP INC reported Diluted EPS of $5.93 per share (loss) for fiscal year 2025.
- OCTAVE SPECIALTY GROUP INC showed an increase of +50.4% in Diluted EPS compared to the prior fiscal year.
- OCTAVE SPECIALTY GROUP INC reported Total Assets of $2.22 billion for fiscal year 2025.
- OCTAVE SPECIALTY GROUP INC showed a decrease of -72.4% in Total Assets compared to the prior fiscal year.
- OCTAVE SPECIALTY GROUP INC reported Cash and Equivalents of $17.00 million for fiscal year 2021.
- OCTAVE SPECIALTY GROUP INC showed a decrease of -15.0% in Cash and Equivalents compared to the prior fiscal year.
- OCTAVE SPECIALTY GROUP INC reported Long-Term Debt of $117.56 million for fiscal year 2025.
- OCTAVE SPECIALTY GROUP INC showed an increase of +17.6% in Long-Term Debt compared to the prior fiscal year.
- OCTAVE SPECIALTY GROUP INC reported Stockholders Equity of $715.79 million for fiscal year 2025.
- OCTAVE SPECIALTY GROUP INC showed a decrease of -10.3% in Stockholders Equity compared to the prior fiscal year.
- OCTAVE SPECIALTY GROUP INC reported Shares Outstanding of 45.01 million shares for fiscal year 2025.
- OCTAVE SPECIALTY GROUP INC showed a decrease of -3.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: